BackTurn Therapeutics Overview

Turn Therapeutics Operating Income

Track Turn Therapeutics's operating income ($-7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

-$1.63M
↓ 19.14% YoY

As of Jun 30, 2026

Annual Operating Income (TTM)

-$6.98M

Trailing 12 months ending Jun 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Turn Therapeutics (TTRX) FAQ

As of the most recent data (June 2026), TTRX shows a operating income of $-7M. Scroll down for historical charts and peer comparison views.

Tracking TTRX's operating income over time shows whether Turn Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $-7M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Turn Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-7M) with ownership activity and broader fundamentals.

Turn Therapeutics's operating income is $-7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.